The New York Times reports The Food and Drug Administration rejected another new diet pill on Thursday, a decision that sharply diminished the already scarce number of options available to overweight Americans amid the nation's obesity epidemic.
http://www.nytimes.com/2010/10/29/health/policy/29drug.html?emc=na
The rejected drug, called Qnexa, is the third weight loss drug to suffer a significant setback this month because of concerns about safety, as federal regulators seem to have heightened their scrutiny of diet pills that could pose risks to the heart or other organs. Last week, the F.D.A. declined to approve another new drug, lorcaserin, and earlier in the month it forced the withdrawal of Meridia from the market after 13 years, citing the risk of heart attacks and strokes for certain patients.
No comments:
Post a Comment